Rytus Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 6.25 Cr
- Paid Up Capital ₹ 6.21 Cr
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.85 Cr
- Revenue Growth 62.76%
- Profit Growth 35.29%
- Ebitda 49.11%
- Net Worth -251.16%
- Total Assets -20.30%
About Rytus Therapeutics
Rytus Therapeutics Limited (RTL) is Under Cirp company established on 21 Feb 2011 with its office registered at Thane, Maharashtra, India and has been running since 14 Year, 1 Month with a paid up capital of 6.21 Cr. According to MCA records, 3 Directors are linked to this company as of 18 Jan 2025.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100MH2011PLC213828
- Company No.
213828
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Rytus Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Swaroop  | Whole-Time Director | 21-Feb-2011 | Current |
| Abhinna Sundar | Director | 21-Feb-2011 | Current |
| Manas Patnaik | Additional Director | 01-Dec-2021 | Current |
Financial Performance of Rytus Therapeutics.
Rytus Therapeutics Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 62.76% increase. The company also saw a substantial improvement in profitability, with a 35.29% increase in profit. The company's net worth observed a substantial decline by a decrease of 251.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rytus Therapeutics?
In 2015, Rytus Therapeutics had a promoter holding of 41.43% and a public holding of 58.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Marksans Pharma LimitedAbhinna Sundar is a mutual person
- Rytus Healthcare Foundation
Anand Swaroop and Abhinna Sundar are mutual person
- Ssb Seva Kartavya Foundation
Anand Swaroop and Abhinna Sundar are mutual person
- Candaur Pharmaceuticals Private Limited
Manas Patnaik is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹1.85 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.10 Cr
- Tamilnad Mercantile Bank Limited : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2013 | Axis Bank Limited | ₹1.10 Cr | Satisfied |
| 05 Oct 2011 | Tamilnad Mercantile Bank Limited | ₹7.50 M | Satisfied |
How Many Employees Work at Rytus Therapeutics?
Unlock and access historical data on people associated with Rytus Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rytus Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rytus Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Rytus Therapeutics
Recent activity within the organization
- Annual General Meeting
Rytus Therapeutics Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Rytus Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
- Director Appointment
Manas Ranjan Patnaik was appointed as a Additional Director was appointed as a Additional Director on 01 Dec 2021 & has been associated with this company since 3 years 3 months .
- Charges
A charge registered on 26 Feb 2013 via Charge ID 10408148 with Axis Bank Limited was fully satisfied on 16 Dec 2013.
- Charges
A charge with Axis Bank Limited of Rs. 1.10 Cr registered on 26 Feb 2013 with Charge ID 10408148 was modified on 09 Oct 2013.
- Charges
A charge registered on 05 Oct 2011 via Charge ID 10313207 with Tamilnad Mercantile Bank Limited was fully satisfied on 09 Mar 2013.
Frequently asked questions
What is the Incorporation or founding date of Rytus Therapeutics Limited?
Rytus Therapeutics Limited was incorporated on 21 Feb 2011.
What is authorized share capital and paid-up capital of Rytus Therapeutics Limited?
The authorized share capital of Rytus Therapeutics Limited is ₹ 6.25 Cr and paid-up capital is ₹ 6.21 Cr.
Who are the current board members & directors of Rytus Therapeutics Limited?
Currently 3 directors are associated with Rytus Therapeutics Limited.
- Anand Mohanty Swaroop
- Manas Ranjan Patnaik
- Abhinna Mohanty Sundar
What is the registered address of Rytus Therapeutics Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Rytus Therapeutics Limited is Flat No.1601 16Th Floor Willowcrest Building One Hiranandani Park Ghodbunder Road, Th Ane West India, Thane, Maharashtra, 400607.
What is the corporate identification number (CIN) and company number of Rytus Therapeutics Limited?
The corporate identification number (CIN) of Rytus Therapeutics Limited is U24100MH2011PLC213828 and the company number is 213828 as per Ministry of Corporate Affairs (MCA).
What is the official website of Rytus Therapeutics Limited?
The Official website of Rytus Therapeutics Limited is https://www.rytus.in
What has been the recent revenue trend for Rytus Therapeutics Limited?
According to the financial reports for the fiscal year 2015, the revenue trend for Rytus Therapeutics Limited has risen by 62.76%.
What change has been observed in the net worth of Rytus Therapeutics Limited, and by what percentage?
The financial reports for the fiscal year 2015 indicates that The net worth of Rytus Therapeutics Limited has experienced an downturn of -251.16%.
When was the last Balance Sheet of Rytus Therapeutics Limited filed with the ROC?
The most recent Balance Sheet for Rytus Therapeutics Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
AS
Akhilesh SharmaDirectorSM
Supriya MohantyDirector